Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 -6.252M
June 30, 2024 -9.241M
March 31, 2024 -11.68M
December 31, 2023 -9.416M
September 30, 2023 -13.46M
June 30, 2023 -12.39M
March 31, 2023 -12.94M
December 31, 2022 -10.33M
September 30, 2022 -15.90M
June 30, 2022 -9.956M
March 31, 2022 -14.44M
December 31, 2021 -9.842M
September 30, 2021 -9.727M
June 30, 2021 -10.60M
March 31, 2021 -8.708M
December 31, 2020 -8.75M
September 30, 2020 -6.234M
June 30, 2020 -13.49M
March 31, 2020 -14.74M
December 31, 2019 -10.12M
September 30, 2019 -13.54M
June 30, 2019 -8.84M
March 31, 2019 -12.87M
Date Value
December 31, 2018 -9.688M
September 30, 2018 -10.09M
June 30, 2018 -8.614M
March 31, 2018 -11.74M
December 31, 2017 -11.08M
September 30, 2017 -11.66M
June 30, 2017 -12.22M
March 31, 2017 -12.76M
December 31, 2016 -10.30M
September 30, 2016 -11.36M
June 30, 2016 -12.95M
March 31, 2016 -11.84M
December 31, 2015 -8.82M
September 30, 2015 -11.25M
June 30, 2015 -9.998M
March 31, 2015 -7.394M
December 31, 2014 -8.485M
September 30, 2014 -7.508M
June 30, 2014 -6.40M
March 31, 2014 -5.791M
December 31, 2013 -4.578M
September 30, 2013 -4.959M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
ABVC BioPharma, Inc. -0.4389M
Anika Therapeutics, Inc. 8.377M
Perspective Therapeutics, Inc. -31.35M
MiMedx Group, Inc. 3.791M
Abbott Laboratories 1.737B